Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
SailPoint Launches Follow-On Offering by Selling Stockholders
-
Dycom Industries (DY) PT Lowered to $90 at Canaccord Genuity
-
Hologic (HOLX) PT Lowered to $41 at Canaccord Genuity
-
Exact Sciences (EXAS) PT Raised to $65 at Canaccord Genuity
-
Canaccord Genuity Group Inc. Announces Completion of its Investment to Increase Ownership of its Australian Business
-
Canaccord Genuity Group Inc. Discloses Normal Course Issuer Bid
-
Maricann Group Announces Closing of Previously Announced Private Placement Raising Gross Proceeds of $37.4 Million
-
STAAR Surgical Announces Closing of Common Stock Offering
-
Granite Construction (GVA) PT Lowered to $65 at Canaccord Genuity
-
Dropbox (DBX) PT Raised to $38 at Canaccord Genuity
-
Altair Engineering (ALTR) PT Raised to $38 at Canaccord Genuity
-
Alder Biopharm (ALDR) PT Raised to $22 at Canaccord Genuity
-
Reis, Inc. Announces Second Quarter 2018 Financial Results
-
Reis, Inc. Announces Second Quarter 2018 Financial Results
-
North American Financial 15 Split Corp. Announces Successful Overnight Offering
-
Ampio Pharma (AMPE) Prices 20M Offering of Common Stock and Warrants
-
Ampio Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
-
InterRent REIT Closes $115 Million Bought Deal Financing
-
Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
-
Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
-
Asure Software CEO to Present at Canaccord Genuity’s 2018 Growth Conference
-
Glen Richards-Backed Healthia Limited to List on the ASX$26.8m Initial Public Offer Opens
-
Ampio Pharma (AMPE) Reports Public Offering of Common Stock and Warrants
-
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
TPI Composites, Inc. to Participate at Upcoming Investor Conferences
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Neovasc Announces Updated Presentation Time at the 38th Annual Canaccord Genuity Growth Conference
-
ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference
-
PAR Technology Corporation to Present at Canaccord Genuity 38th Annual Growth Conference
-
STAAR Surgical (STAA) Prices 1.74M Common Stock Offering for Proceeds of $67.8 Million
-
STAAR Surgical Announces Pricing of Public Offering of Common Stock
-
Wayfair to Participate in the Canaccord Genuity 38th Annual Growth Conference
-
STAAR Surgical (STAA) Announces 1.74M Public Offering of Common Stock
-
Aileron Therapeutics Reports Second Quarter 2018 Financial Results
-
Aileron Therapeutics Reports Second Quarter 2018 Financial Results
-
CEVA, Inc. to Present at Upcoming Investor Conferences
-
Five9 Announces Upcoming Conference Participation
-
ICF to Present at 38th Annual Canaccord Genuity Growth Conference
-
Aspen Technology to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Etsy Updates Presentation time for Investor Conference
-
STAAR Surgical Announces Public Offering of Common Stock
-
AeroVironment, Inc. to Present at the Jefferies 2018 Industrials Conference and Canaccord Genuity’s 38th Annual Growth Conference
-
Obalon Announces Upcoming Conference Presentation
-
Obalon Announces Upcoming Conference Presentation
-
iAnthus to Present at Canaccord's 38th Annual Global Growth Conference, MJBizCon International and Benzinga Cannabis Capital Conference
-
Rallybio Welcomes Laura Ekas, PhD and Eric Watsky, MD, Further Expanding Rallybio’s Drug Acquisition and Development Capabilities
-
Canaccord Genuity Starts Deciphera (DCPH) at Buy
-
Canaccord Genuity Starts Ascendis Pharma (ASND) at Buy
-
TransGlobe Energy Corporation Announces Release Date of Second Quarter 2018 Results and Conference Call
-
CORRECTING and REPLACING Civitas Solutions, Inc. to Present at Canaccord Genuity Growth Conference in August

